TITLE

Effects of Etravirine Versus Placebo on Health-Related Quality of Life in Treatment-Experienced HIV Patients as Measured by the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) Questionnaire in the DUET Trials

AUTHOR(S)
Cella, David; Gilet, Hélène; Viala-Danten, Muriel; Peeters, Katrien; Dubois, Dominique; Martin, Silas
PUB. DATE
January 2010
SOURCE
HIV Clinical Trials;Jan/Feb2010, Vol. 11 Issue 1, p18
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To study the effects of etravirine versus placebo on the health-related quality of life (HRQL) of HIV-infected patients.Method: HRQL of HIV-infected patients was measured using the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) questionnaire in two identically designed phase III clinical trials investigating efficacy and safety of etravirine as part of highly active antiretroviral therapy. Pooled analyses of covariance, adjusted for treatment group, baseline FAHI score, CD4 cell count, viral load, and enfuvirtide use helped investigate changes in FAHI scores between baseline and Week 24 in etravirine-treated (n = 599) and placebo-treated (n = 604) subjects. Responder analyses were also conducted.Results: Significant improvements with etravirine treatment were observed for FAHI physical, functional, emotional, and total scores (P < .001). These improvements were greater and statistically different from those with placebo (.013

ACCESSION #
54227217

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics